Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)

Terminated
  • Sarcoma
  • +3 more
  • CMB305
  • +2 more
  • Santa Monica, California
  • +7 more
Jun 29, 2020

Intracranial Tumors, Glioblastoma, Melanoma Trial in Boston (other, biological, radiation)

Completed
Has Results
  • Intracranial Tumors
  • +2 more
  • PBR PET
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 20, 2020

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Tumors, Tumor Metastasis, Melanoma Trial in Worldwide (LY3009120 capsule)

Terminated
Has Results
  • Neoplasms
  • +4 more
  • LY3009120 capsule
  • Scottsdale, Arizona
  • +5 more
Dec 20, 2019

Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

Completed
  • Lung Cancer
  • +7 more
  • Chicago, Illinois
  • +5 more
Nov 15, 2019

Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1

Terminated
Has Results
  • Melanoma
  • glembatumumab vedotin
  • +3 more
  • Los Angeles, California
  • +13 more
Sep 5, 2019

Tumors, Melanoma, Colorectal Tumor Trial in United States (ASN003 ascending doses, ASN003 MTD)

Terminated
  • Neoplasms
  • +3 more
  • ASN003 ascending doses
  • ASN003 MTD
  • Los Angeles, California
  • +4 more
May 17, 2019

Melanoma Trial in Worldwide (Durvalumab, Dabrafenib, Trametinib)

Completed
  • Melanoma
  • Durvalumab
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 15, 2019

Melanoma Trial in United States (Vemurafenib, Cobimetinib)

Terminated
Has Results
  • Melanoma
  • Washington, District of Columbia
  • +3 more
Feb 6, 2019

Safety of Ipilimumab Administered in EAP Advanced Melanoma

Completed
  • Melanoma
    • Boston, Massachusetts
    • +16 more
    Jan 28, 2019

    Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

    Completed
    Has Results
    • Mucosal Lentiginous Melanoma
    • +2 more
    • Santa Monica, California
    • +7 more
    Oct 16, 2018

    Melanoma Trial in United States (Ipilimumab, Vemurafenib)

    Completed
    Has Results
    • Melanoma
    • Beverly Hills, California
    • +13 more
    Jun 26, 2018

    Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

    Terminated
    • Carcinoma, Renal Cell
    • +13 more
    • Combination of Varlilumab and Atezolizumab
    • San Francisco, California
    • +3 more
    Apr 26, 2018

    Melanoma Trial in Worldwide (GSK1120212, Chemotherapy)

    Completed
    Has Results
    • Melanoma
    • Tucson, Arizona
    • +111 more
    Mar 9, 2018

    Participants Treated With Ipilimumab-Nivolumab Combination

    Completed
    • Melanoma
    • Non-Interventional
    • Boston, Massachusetts
      Local Institution
    Feb 16, 2018

    Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)

    Terminated
    Has Results
    • Melanoma
    • Metastatic Melanoma
    • Los Angeles, California
    • +13 more
    Sep 22, 2017

    Ovarian Cancer, Cervical Cancer, Uterine Cancer Trial in Boston (communication with oncology team)

    Completed
    • Ovarian Cancer
    • +5 more
    • communication with oncology team
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 15, 2017

    Melanoma Trial in Boston (STA-9090)

    Terminated
    Has Results
    • Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 1, 2017

    Melanoma Trial in Boston (Aldesleukin, Vemurafenib)

    Terminated
    Has Results
    • Melanoma
    • Boston, Massachusetts
    • +1 more
    Mar 14, 2017

    Melanoma Trial in Boston (Vemurafenib, Leflunomide)

    Terminated
    • Melanoma
    • Boston, Massachusetts
    • +2 more
    Apr 4, 2017

    Melanoma, Malignant Melanoma Trial in Boston (LBH589)

    Completed
    • Melanoma
    • Malignant Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 27, 2017

    Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B

    Completed
    Has Results
    • Locally Advanced Solid Tumor
    • +5 more
    • MSC1936369B (pimasertib)
    • SAR245409 (PI3K and mTOR inhibitor)
    • Scottsdale, Arizona
    • +7 more
    Jan 17, 2017

    Melanoma Trial in Boston (ICG Intervention)

    Completed
    • Melanoma
    • ICG Intervention
    • Boston, Massachusetts
    • +1 more
    Feb 2, 2017

    Melanoma Trial in Worldwide (Talimogene laherparepvec, GM-CSF)

    Completed
    Has Results
    • Melanoma
    • Talimogene laherparepvec
    • GM-CSF
    • Tucson, Arizona
    • +82 more
    Jun 14, 2016

    Melanoma Trial in Boston (bortezomib, sorafenib)

    Completed
    • Melanoma
    • Boston, Massachusetts
    • +2 more
    Jun 7, 2016